Key result
ACE inhibitors and ARBs may improve clinical outcomes in patients with heart failure with preserved ejection fraction.
Why the study?
Do ACE-I and ARBs improve outcomes in patients with HFpEF?
Do ACE-I and ARBs improve outcomes in patients with HFpEF?
Answers are grounded in this paper and cite their sources.
ACE-I and ARBs may have a role in improving outcomes in HFpEF, highlighting the need for further research with careful patient selection.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Khan et al. (2017) studied this question. ACE inhibitors and ARBs may improve clinical outcomes in patients with heart failure with preserved ejection fraction.
Synapse has enriched 10 related papers. Consider them for comparative context: